Cargando…

Successful treatment of prolonged COVID-19 with Bamlanivimab in a patient with severe B-Cell aplasia due to treatment with an anti-CD20 monoclonal antibody: A case report

A 71-year-old female patient with B-cell depletion due to treatment with an anti-CD20 monoclonal antibody was admitted for worsening COVID-19. Overall, she had persistent viral shedding, worsening respiratory failure, and progressive pneumonia that did not improve despite dexamethasone and antibioti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daher, Ayham, Müller, Tobias, Spiesshoefer, Jens, Dreher, Michael, Panse, Jens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628608/ https://www.ncbi.nlm.nih.gov/pubmed/34868871 http://dx.doi.org/10.1016/j.rmcr.2021.101560

Ejemplares similares

Cardiopulmonary work up of patients with and without fatigue 6 months after COVID-19
por: Thiele, Kirsten, et al.
Publicado: (2022)

Diaphragm Muscle Weakness Might Explain Exertional Dyspnea 15 Months after Hospitalization for COVID-19
por: Regmi, Binaya, et al.
Publicado: (2023)

Diaphragm dysfunction as a potential determinant of dyspnea on exertion in patients 1 year after COVID-19-related ARDS
por: Spiesshoefer, Jens, et al.
Publicado: (2022)

Bamlanivimab Monoclonal Antibody Treatment in Patients with Graft Versus Host Disease (GVHD) Diagnosed with COVID-19 Infection
por: Faisal, Muhammad Salman, et al.
Publicado: (2022)

Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Bariola, J Ryan, et al.
Publicado: (2021)

Broncho‐alveolar lavage in patients with acute respiratory distress syndrome due to COVID‐19
por: Cornelissen, Christian G., et al.
Publicado: (2021)

Pulmonary infections in patients with and without hematological malignancies: diagnostic yield and safety of flexible bronchoscopy—a retrospective analysis
por: Panse, Jens, et al.
Publicado: (2020)

Pure Red Cell Aplasia with Del(20q) Sensitive for Immunosuppressive Treatment
por: Vo, Anh Khoi, et al.
Publicado: (2020)

BAMLANIVIMAB-INDUCED GUILLAIN-BARRÉ SYNDROME
por: PALAGUACHI, GLADYS, et al.
Publicado: (2021)

500. A Real-World Cohort Study of Bamlanivimab Versus Bamlanivimab-Etesevimab for Non-severe COVID-19
por: Monday, Lea, et al.
Publicado: (2021)

Bamlanivimab: Guillain-Barre syndrome: case report
Publicado: (2021)

Bamlanivimab: New-onset seizures: case report
Publicado: (2022)

Health System Success in Delivering Bamlanivimab Within Post-acute and Long-Term Care Facilities
por: Walker, Victoria L., et al.
Publicado: (2022)

Evaluation of Implant Success in Patients with Dental Aplasia
por: Attia, Sameh, et al.
Publicado: (2019)

Significance of Hypocapnia in the Risk Assessment of Patients with Pulmonary Hypertension
por: Aetou, Maria, et al.
Publicado: (2023)

Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab
por: Sims, Jonathan T., et al.
Publicado: (2022)

Molecular rationale for SARS-CoV-2 spike circulating mutations able to escape bamlanivimab and etesevimab monoclonal antibodies
por: Laurini, Erik, et al.
Publicado: (2021)

Effects of Transcatheter Mitral Valve Repair Using MitraClip(®) Device on Sleep Disordered Breathing in Patients with Mitral Valve Regurgitation
por: Daher, Ayham, et al.
Publicado: (2021)

Effects of COPD on Left Ventricular and Left Atrial Deformation in Patients with Acute Myocardial Infarction: Strain Analysis Using Speckle-Tracking Echocardiography
por: Grebe, Julian, et al.
Publicado: (2022)

Recurrent idiopathic membranous nephropathy in the renal allograft: successful treatment with the anti-CD20 monoclonal antibody rituximab
por: Ladino, Marco, et al.
Publicado: (2009)

Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
por: Dougan, Michael, et al.
Publicado: (2021)

Bamlanivimab infusion experience at one academic emergency department
por: Yoo, Michael J., et al.
Publicado: (2022)

Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19
por: Destras, Grégory, et al.
Publicado: (2021)

The anti-SARS-CoV-2 monoclonal antibody, bamlanivimab, minimally impacts the endogenous immune response to COVID-19 vaccination
por: Benschop, Robert J., et al.
Publicado: (2022)

Foetal Liver Suspensions in the Treatment of Marrow Aplasia
por: Bridges, J. B., et al.
Publicado: (1965)

Six Months Follow-Up of Patients with Invasive Mechanical Ventilation Due to COVID-19 Related ARDS
por: Daher, Ayham, et al.
Publicado: (2021)

Clinical course of COVID-19 patients needing supplemental oxygen outside the intensive care unit
por: Daher, Ayham, et al.
Publicado: (2021)

Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together
por: Zhang, Lin, et al.
Publicado: (2021)

Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae
por: Daher, Ayham, et al.
Publicado: (2020)

PK/PD modeling links accelerated resolution of COVID‐19‐related clinical symptoms to SARS‐CoV‐2 viral load reduction in patients following treatment with Bamlanivimab alone or Bamlanivimab and Etesevimab together
por: Ernest, C. Steven, et al.
Publicado: (2022)

Monoclonal antibody infusion reaction with bamlanivimab and etesevimab in a 5-year-old male with coronavirus disease 2019: a case report
por: Pillai, Rajapillai L. I., et al.
Publicado: (2023)

Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients
por: Jan, Muhammad Y., et al.
Publicado: (2021)

Real World Utilization of Bamlanivimab at a Rural Community Hospital
por: Leavitt, Rachael, et al.
Publicado: (2021)

Bamlanivimab/immunosuppressants: Headache/fatigue following off-label treatment and Coronavirus disease-2019: 18 case reports
Publicado: (2022)

Successful Treatment of Antibody-mediated Pure Red Cell Aplasia Induced by Continuous Erythropoietin Receptor Activator with Prednisolone
por: Okahashi, Nozomi, et al.
Publicado: (2021)

Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment
por: Du, Fanny Huynh, et al.
Publicado: (2017)

Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin
por: Ly, Sophia, et al.
Publicado: (2023)

542. Use of Bamlanivimab in Cancer Patients with Mild-to-Moderate COVID-19
por: Brock, Patricia, et al.
Publicado: (2021)

Pure red cell aplasia due to azathioprine therapy for Crohn's disease
por: Kamath, Nagesh, et al.
Publicado: (2016)

Becker’s Naevus Syndrome with Breast Aplasia Due to Postzygotic Mutation of ACTB
por: RAMSPACHER, Jeanne, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9r1pircf43p3iidkmck0ljbbur